Damora Therapeutics, Inc. (DMRA) Insider Trading

Name: Damora Therapeutics, Inc. (DMRA) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 28, 2026): Jarrett Jennifer (Director, President and CEO): Purchase of 12,500 shares, $252.9K.

Get alerted when insiders trade DMRA

Email address

Loading company data...

Loading company details...